GNTA
Genenta Science SpA ADR
NASDAQ: GNTA · HEALTHCARE · BIOTECHNOLOGY
$0.71
-1.99% today
Updated 2026-04-29
Market cap
$16.71M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.39
Dividend yield
—
52W range
$1 – $6
Volume
0.1M
Genenta Science SpA ADR (GNTA) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | $-2.49M | $-6.04M | $-6.96M | $-7.42M | $-11.21M | $-6.24M | $-6.87M |
| Capital expenditures | $20871.00 | $20871.00 | $9009.00 | $27070.00 | $13791.00 | $4468.00 | $7625.00 |
| Depreciation | $1900.00 | $1900.00 | $4889.00 | $6140.00 | $42453.00 | $44523.00 | — |
| Stock-based comp | $749512.00 | $460194.00 | $497104.00 | $722735.00 | $739884.00 | $847255.00 | $1.01M |
| Free cash flow | $-2.51M | $-6.07M | $-6.97M | $-7.45M | $-11.22M | $-6.24M | $-6.88M |
| Investing cash flow | $-20871.00 | $-20871.00 | $-9009.00 | $-27070.00 | $-14.89M | $6.88M | — |
| Financing cash flow | $14.77M | $1.39M | $28.74M | $0.00 | $531.00 | $270885.00 | — |
| Dividends paid | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — |